Segui
Prashanth Reddy
Titolo
Citata da
Citata da
Anno
Euro I nf: AM ulticenter C omparative O bservational S tudy of A pomorphine and L evodopa I nfusion in P arkinson's D isease
P Martinez‐Martin, P Reddy, R Katzenschlager, A Antonini, A Todorova, ...
Movement Disorders 30 (4), 510-516, 2015
2492015
EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
HS Dafsari, P Martinez‐Martin, A Rizos, M Trost, MG dos Santos Ghilardi, ...
Movement disorders 34 (3), 353-365, 2019
1422019
Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect
P Martinez-Martin, P Reddy, A Antonini, T Henriksen, R Katzenschlager, ...
Journal of Parkinson's disease 1 (2), 197-203, 2011
1282011
Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson's disease
HS Dafsari, P Reddy, C Herchenbach, S Wawro, JN Petry-Schmelzer, ...
Brain stimulation 9 (1), 78-85, 2016
1112016
Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects
P Reddy, P Martinez-Martin, A Rizos, A Martin, GC Faye, I Forgacs, ...
Clinical neuropharmacology 35 (5), 205-207, 2012
612012
Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease …
P Reddy, P Martinez-Martin, RG Brown, KR Chaudhuri, JP Lin, R Selway, ...
Health and Quality of Life Outcomes 12, 1-10, 2014
502014
Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease
HS Dafsari, L Weiß, M Silverdale, A Rizos, P Reddy, K Ashkan, J Evans, ...
Brain stimulation 11 (4), 867-874, 2018
442018
Narcolepsy in Parkinson’s disease
IZ Haq, Y Naidu, P Reddy, KR Chaudhuri
Expert Review of Neurotherapeutics 10 (6), 879-884, 2010
352010
Subthalamic stimulation improves quality of life of patients aged 61 years or older with short duration of Parkinson’s disease
HS Dafsari, P Reker, M Silverdale, P Reddy, M Pilleri, P Martinez-Martin, ...
Neuromodulation: Technology at the Neural Interface 21 (6), 532-540, 2018
342018
Noninvasive options for ‘wearing-off’in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists
R Fackrell, CB Carroll, DG Grosset, B Mohamed, P Reddy, M Parry, ...
Neurodegenerative disease management 8 (5), 349-360, 2018
322018
The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease
K Ashkan, M Samuel, P Reddy, K Ray Chaudhuri
Journal of Neural Transmission 120, 639-642, 2013
312013
Rasagiline‐induced serotonin syndrome
C Fernandes, P Reddy, B Kessel
Movement Disorders 26 (4), 766-767, 2011
222011
Handbook of movement disorders
KR Chaudhuri, WG Ondo, K Logishetty, P Reddy, R Sherman
Current Medicine Group, 2009
212009
EUROPAR and the International Parkinson and movement disorders Society non-motor Parkinson's disease Study Group. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa …
HS Dafsari, P Martinez-Martin, A Rizos, M Trost, MG Dos Santos Ghilardi, ...
Mov Disord 34 (3), 353-365, 2019
202019
Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson’s disease compared to conventional therapy: A real life study of non motor effect. J. Parkinson’s …
P Martinez-Martin, P Reddy, A Antonini, T Henriksen, R Katzenschlager, ...
JPD-2011-11037.[Abstract][CrossRef][Google Scholar], 0
15
Evaluation of simvastatin as a disease-modifying treatment for patients with Parkinson disease: a randomized clinical trial
KN Stevens, S Creanor, A Jeffery, A Whone, J Zajicek, A Foggo, B Jones, ...
JAMA neurology 79 (12), 1232-1241, 2022
142022
Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease
A Todorova, P Martinez-Martin, A Martin, A Rizos, P Reddy, ...
Basal Ganglia 3 (2), 127-130, 2013
132013
European multicentre survey of tolerability rates and impulse control behaviour trends of prolonged release dopamine agonists in young and old PD
A Rizos, P Martinez-Martin, A Martin, T Henriksen, B Kessel, I Koch, ...
Movement Disorders 27, S50-S50, 2012
92012
Praktische Anwendung der kontinuierlichen Apomorphin-Pumpentherapie
L Tönges, A Ceballos-Baumann, H Honig, A Storch, WH Jost
Fortschritte der Neurologie· Psychiatrie 85 (09), 516-535, 2017
82017
P2. 149 Efflcacy of apomorphine infusion on mood and depression aspects of non-motor symptoms in advanced Parkinson's disease
Y Naidu, K Logishetty, A Martin, S Tluk, P Reddy, P Martinez-Martin, ...
Parkinsonism and Related Disorders, S130, 2009
82009
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20